Characterization of Recombinant Vaccinia Viruses by MLPA Technology
نویسندگان
چکیده
منابع مشابه
Transient dominant selection of recombinant vaccinia viruses.
A general method for constructing and selecting recombinant vaccinia viruses with insertions, deletions, or mutations in any gene that is similar in principle to one originally devised for Saccharomyces cerevisiae (S. Scherer and R. W. Davis, Proc. Natl. Acad. Sci. USA 76:4951-4955, 1979) is described. The selectable marker used, Escherichia coli guanine phosphoribosyltransferase, is not retain...
متن کاملCharacterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.
Hepatitis E virus (HEV), an enterically transmitted pathogen, is one of the major causes of acute hepatitis in humans worldwide, being responsible for outbreaks and epidemics in regions with suboptimal sanitary conditions, in many of which it is endemic. In industrialized countries, hepatitis E is rarely reported, but recent studies have revealed quite high human seroprevalence rates and the po...
متن کاملRecombinant vaccinia viruses as live vaccines.
Recombinant vaccinia viruses can be constructed that express foreign antigens. These viruses retain their infectivity and synthesise the foreign gene product in tissue culture and in vaccinated animals. Following vaccination, specific antibody and cell-mediated immune responses are generated against the foreign protein and in several cases these have protected the animal against subsequent chal...
متن کاملExpression of wild-type and mutant p53 proteins by recombinant vaccinia viruses
To facilitate the purification of wild type p53 protein, we established a recombinant p53 vaccinia viral expression system. Using this efficient eukaryotic expression vector, we found that the expressed p53 proteins retained their specific structural characteristics. A comparison between wild type and mutant p53 proteins showed the conservation of the typical subcellular localization and the ex...
متن کاملInduction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules.
Activation of T cells requires at least two signals: an antigen-specific signal delivered through the T-cell receptor and a costimulatory signal mediated through molecules designated B7-1 and B7-2. Previous studies have shown that introduction of B7-1 and B7-2 into tumors using retroviral vectors has led to enhanced antitumor effects. A limiting factor for potential clinical applications using ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Applied Biosafety
سال: 2014
ISSN: 1535-6760,2470-1246
DOI: 10.1177/153567601401900304